Could cause temporary or reversible harm; serious harm is unlikely.
Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.
| Brand name | ADVIL |
| Generic name | IBUPROFEN |
| Active ingredient(s) | IBUPROFEN |
| Distributed by / for | Glaxosmithkline Consumer Healthcare Holdings |
| NDC | 0573-1769-89 |
| Full product label | Ibuprofen 200 mg liquid filled capsules Advil Liqui-Gel Minis, 160 count bottle NDC 0573-1769-89 NDC 0573-1769-95 |
| Recalling firm | Glaxosmithkline Consumer Healthcare Holdings |
| Distribution | Product was distributed throughout the United States, including Puerto Rico. |
| Quantity | 446,628 bottles |
| Recall initiated | 2020-03-16 |
| Report date | 2020-04-01 |
| Recall completed | 2021-10-28 |
| Recall number | D-1066-2020 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Warren NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗